Understanding how cell signaling networks affect cancer and cell movement

Deciphering the network structure of signaling dynamics

NIH-funded research Johns Hopkins University · NIH-10813163

This study is looking at how certain signals in cancer cells help them move and survive, which could lead to new ways to treat cancer and help patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10813163 on NIH RePORTER

What this research studies

This research investigates the complex signaling network involving Ras GTPases and their effects on cellular processes such as migration and survival, which are crucial in cancer development. By using advanced fluorescent live cell imaging techniques, the study aims to systematically analyze how perturbations in this signaling network influence its dynamics. Patients may benefit from insights gained about how cancer cells move and proliferate, potentially leading to new therapeutic strategies. The research focuses on understanding the underlying mechanisms that could be targeted for improved cancer treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with cancers that exhibit abnormal cell signaling and migration patterns.

Not a fit: Patients with non-malignant conditions or those whose cancers do not involve the Ras signaling network may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating cancers by targeting the signaling pathways that control cell movement and growth.

How similar studies have performed: Previous research has shown promising results in understanding cell signaling dynamics, indicating that this approach could yield valuable insights.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancersneoplasm/cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.